Impact Biomedical (IBO) Research & Development (2022 - 2026)
Impact Biomedical (IBO) posted Research & Development of $1000.0 for Q1 2026, down 50.0% on a QoQ basis from $2000.0 in Q3 2025, and down 94.74% year-over-year from $19000.0 in Q1 2025.
Impact Biomedical (IBO) Research & Development (2022 - 2026) Analysis & Trends
Impact Biomedical's Research & Development history runs 5 years deep, the most recent figure standing at $1000.0 for Q1 2026.
- Quarterly Research & Development fell 94.74% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23000.0 (down 92.04% YoY) and the FY2024 annual result came in at $278000.0, up 327.69% from the prior year.
- Research & Development was $1000.0 for Q1 2026 at Impact Biomedical, down from $2000.0 in the prior quarter.
- Across five years, Research & Development topped out at $522000.0 in Q4 2022 and bottomed at -$990000.0 in Q4 2023.
- A 5-year average of $55266.7 and a median of $18000.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development tumbled 289.66% — and 2024, when it soared 2611.76%.
- Impact Biomedical's Research & Development stood at $522000.0 in 2022, then tumbled by 289.66% to -$990000.0 in 2023, then soared by 78.89% to -$209000.0 in 2024, then soared by 100.96% to $2000.0 in 2025, then plunged by 50.0% to $1000.0 in 2026.
- Business Quant data shows IBO's Research & Development at $1000.0 in Q1 2026, $2000.0 in Q3 2025, and $1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -209,000.00 |
| Sep 30, 2024 | 461,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | -990,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | 522,000.00 |
| Sep 30, 2022 | 330,000.00 |
| Jun 30, 2022 | 206,000.00 |